Rapid Cardiac Markers
Rapid detection of troponin, CK-MB or myoglobin in a blood specimen can be the difference between life and death in cases of myocardial infarction. Given the widespread occurrence of heart attacks among increasingly heavy populations across developed and developing nations – this is a valuable (in every sense of the word) technology to get involved in. Find the latest and most informative reports below.
U.S. Cardiac Biomarkers Diagnostics Markets
This research service analyzes the market for cardiac biomarkers within the United States The United States market was divided into the acute myocardial infarction diagnostics and congestive heart failure...
EUR 5518USD 6,000GBP 4,112AUD 7,833JPY 735,267SEK 51 478CHF 5 600CAD 7,755
Successful Management of Heart Failure Patients: Multidisciplinary Approach to Reducing Readmissions
Approximately 5 million people in the United States have heart failure, with 550,000 new cases diagnosed annually The condition is the number one cause for hospitalization among the elderly; one fifth...
EUR 89USD 97GBP 66AUD 127JPY 11,887SEK 832CHF 91CAD 125